EMV.AX ASX
EMVision Medical Devices Ltd
1W: -10.3%
1M: -12.4%
3M: +0.7%
YTD: -13.3%
1Y: -19.2%
3Y: -4.3%
5Y: -46.8%
A$1.62 ($1.13)
+0.06 (+3.85%)
Weekly Expected Move ±5.6%
A$1
A$1
A$2
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$417K
-108.3% ▼
Operating Income
-$17M
-108.3% ▼
Net Income
-$8M
+15.2% ▲
EPS (Diluted)
$-0.09
+17.0% ▲
EBITDA
-$17M
-89.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4M | $7M | $11M | $5M | $0 |
| YoY Growth | +156.7% | +59.9% | +60.9% | -55.0% | -100.0% |
| Cost of Revenue | $243K | $342K | $0 | $0 | $417K |
| Gross Profit | $4M | $7M | $11M | $5M | -$417K |
| Gross Margin | 94.4% | 95.1% | 100.0% | 100.0% | — |
| R&D Expenses | $2M | $2M | $5M | $4M | $5M |
| SG&A Expenses | $8M | $9M | $8M | $9M | $12M |
| Operating Expenses | $10M | $11M | $13M | $13M | $17M |
| Operating Income | -$10M | -$11M | -$2M | -$8M | -$17M |
| Operating Margin | -240.1% | -156.7% | -14.4% | -160.9% | — |
| Interest Expense | $18K | $35K | $116K | $89K | $203K |
| Income Before Tax | -$8M | -$6M | -$2M | -$8M | -$13M |
| Tax Expense | -$2M | -$3M | $698K | $1M | -$5M |
| Net Income | -$6M | -$4M | -$3M | -$10M | -$8M |
| Net Margin | -140.1% | -55.5% | -24.3% | -194.1% | — |
| EPS (Diluted) | $-0.08 | $-0.05 | $-0.03 | $-0.11 | $-0.09 |
| EBITDA | -$8M | -$6M | -$8M | -$9M | -$17M |
| Shares Outstanding | 75M | 78M | 80M | 85M | 91M |